Nascent Biotech, Inc. (NBIO)
USD 0.01
(44.44%)
USD 0.01
(44.44%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.18 Million | -1.78 Million | 413.47 Thousand | -986.78 Thousand | -554.32 Thousand | -711.8 Thousand |
| Net Income | -2.08 Million | -2.8 Million | -470.39 Thousand | -958.76 Thousand | -4 Million | -1.36 Million |
| Depreciation & Amortization | 377.9 Thousand | 1.34 Million | - | - | - | - |
| Deferred income taxes | - | 245.51 Thousand | - | - | - | - |
| Stock-based compensation | 882.09 Thousand | 756.32 Thousand | 116.08 Thousand | 785.85 Thousand | 1.1 Million | 208.43 Thousand |
| Change in working capital | 163.78 Thousand | -317.33 Thousand | 911.17 Thousand | -102.51 Thousand | 1.81 Million | 410.26 Thousand |
| Other non-cash items | 476.86 Thousand | -1.01 Million | -143.39 Thousand | -711.35 Thousand | 530.15 Thousand | 38.4 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.38 Million | 1.86 Million | -320.5 Thousand | 985 Thousand | 426.07 Thousand | 726.28 Thousand |
| Debt repayment | -175 Thousand | -1.65 Million | -520.5 Thousand | -345 Thousand | -200 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.56 Million | 208 Thousand | - | 640 Thousand | 115 Thousand | 643 Thousand |
| Other Financing Activities | -175 Thousand | 1.86 Million | 200 Thousand | 690 Thousand | 511.07 Thousand | 83.28 Thousand |
| Accounts receivables | - | - | 750 Thousand | -750 Thousand | - | - |
| Accounts payables | 260.96 Thousand | -245.51 Thousand | 167.06 Thousand | 230.4 Thousand | 327.02 Thousand | 322.26 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -97.18 Thousand | 245.51 Thousand | -5884.00 | 417.08 Thousand | 1.48 Million | 88 Thousand |
| Cash at beginning of period | 172.18 Thousand | 94.41 Thousand | 1435.00 | 3218.00 | 131.47 Thousand | 116.99 Thousand |
| Cash at end of period | 372.12 Thousand | 172.18 Thousand | 94.41 Thousand | 1434.00 | 3218.00 | 131.47 Thousand |
| Capital Expenditure | -4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 199.93 Thousand | 77.77 Thousand | 92.97 Thousand | -1784.00 | -128.25 Thousand | 14.47 Thousand |
| Free Cash Flow | -1.18 Million | -1.78 Million | 413.47 Thousand | -986.78 Thousand | -554.32 Thousand | -711.8 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.08 Million | -512.57 Thousand | -205.4 Thousand | -829.47 Thousand | -540.22 Thousand | -2.8 Million |
| Depreciation & Amortization | 377.9 Thousand | 145.52 Thousand | - | - | 232.38 Thousand | 1.34 Million |
| Deferred income taxes | - | 218.93 Thousand | - | - | -218.93 Thousand | 245.51 Thousand |
| Stock-based compensation | 882.09 Thousand | 140.26 Thousand | 77.45 Thousand | 542.1 Thousand | 122.27 Thousand | 756.32 Thousand |
| Change in working capital | 163.78 Thousand | 37.8 Thousand | -56.9 Thousand | -49.42 Thousand | 232.3 Thousand | -317.33 Thousand |
| Other non-cash items | 476.86 Thousand | -79.5 Thousand | -145.25 Thousand | -4707.00 | 9490.00 | -1.01 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.38 Million | 100 Thousand | -50 Thousand | 1.33 Million | 358.25 Thousand | 1.86 Million |
| Debt repayment | -175 Thousand | -175 Thousand | -75 Thousand | -100 Thousand | - | -1.65 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.56 Million | 100 Thousand | 25 Thousand | 1.43 Million | 358.25 Thousand | 208 Thousand |
| Other Financing Activities | -175 Thousand | 100 Thousand | -50.00 | 1336.00 | -358.25 Thousand | 1.86 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 260.96 Thousand | 202.54 Thousand | -26.33 Thousand | -134.17 Thousand | 218.93 Thousand | -245.51 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -97.18 Thousand | -164.73 Thousand | -30.57 Thousand | 84.74 Thousand | -218.93 Thousand | 245.51 Thousand |
| Cash at beginning of period | 172.18 Thousand | 623.85 Thousand | 1 Million | 9480.00 | 172.18 Thousand | 94.41 Thousand |
| Cash at end of period | 372.12 Thousand | 372.12 Thousand | 623.85 Thousand | 1 Million | 9480.00 | 172.18 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 199.93 Thousand | -251.73 Thousand | -380.11 Thousand | 994.48 Thousand | -162.7 Thousand | 77.77 Thousand |
| Free Cash Flow | -1.18 Million | -351.73 Thousand | -330.11 Thousand | -341.51 Thousand | -162.7 Thousand | -1.78 Million |
LAB
3419
6904
600903
AAPT
MHM